[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345942-105":59,"doc-detail-345942-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","modulation-of-prostate-cancer-cell-behavior-through-acetylsalicylic-acid-treated-prostate-epithelial-cell-derived-conditioned-medium-research-article","Modulation of Prostate Cancer Cell Behavior Through Acetylsalicylic Acid-Treated Prostate Epithelial Cell-Derived Conditioned Medium - Research article","","Acetylsalicylic acid (ASA, aspirin) is investigated for its effects on prostate cancer cell behavior via conditioned medium generated by prostate epithelial cells. RWPE-1 epithelial cells were exposed to non-toxic ASA concentrations, and the resulting conditioned media were applied to PC-3 prostate cancer cells. Cell viability was quantified using the MTT assay, migration was measured with wound-healing, and colony formation was also assessed. ASA exposure altered the epithelial secretome and suppressed cancer cell viability and motility, with CM1 (ASA 50 μM) reducing PC-3 viability to 60% and inhibiting migration.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/modulation-of-prostate-cancer-cell-behavior-through-acetylsalicylic-acid-treated-prostate-epithelial-cell-derived-conditioned-medium-research-article/345942/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/modulation-of-prostate-cancer-cell-behavior-through-acetylsalicylic-acid-treated-prostate-epithelial-cell-derived-conditioned-medium-research-article/345942.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How were ASA-treated prostate epithelial conditioned media prepared for the study?","Question",{"text":113,"@type":114},"RWPE-1 prostate epithelial cells were exposed to different ASA concentrations, with non-toxic doses selected. Conditioned media from untreated and ASA-treated RWPE-1 cells were collected and applied to PC-3 prostate cancer cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What methods were used to evaluate PC-3 cancer cell responses?",{"text":118,"@type":114},"Cell viability was assessed using the MTT assay, migration was evaluated with a wound-healing assay, and colony formation was also measured.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the main findings of ASA exposure on prostate cancer cells?",{"text":122,"@type":114},"ASA at 50 μM showed no cytotoxic effect on RWPE-1 cells, while conditioned media from ASA-treated epithelial cells reduced PC-3 viability to 60% and significantly inhibited PC-3 migration. The results indicate that ASA modifies the epithelial secretome to suppress cancer cell viability and motility.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},345942,1790523303,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Cell Biochemistry and Function   \nRESEARCH ARTICLE   \nModulation of Prostate Cancer Cell Behavior Through Acetylsalicylic Acid‐Treated Prostate Epithelial Cell‐Derived Conditioned Medium  \nDilşad Özerkan  | Selda Durukan  | Mahsa Koucheki  | Aysel Nesil  \nDepartment of Genetic and Bioengineering, Faculty of Engineering and Architecture, Kastamonu University, Kastamonu, Turkey Correspondence: Dilşad Özerkan ([dilsadokan@gmail.com](dilsadokan@gmail.com))  \nReceived: 6 November 2025 | Revised: 12 July 2026 | Accepted: 30 July 2026  \nFunding: Scientific and Technological Research Council of TURKEY (TÜBİTAK) 2209 Student Project, Grant/Award Number: 1919B012331787  \nKeywords: acetylsalicylic acid | anti‐cancer | aspirin | chemopreventive | prostate cancer | secretome  \nABSTRACT  \nAcetylsalicylic acid (ASA, aspirin), derived from salicylic acid in willow bark, is known for its analgesic, anti‐inflammatory, and antiplatelet properties. Beyond cardiovascular protection, increasing evidence suggests that ASA may reduce the risk of various cancers, including colorectal and prostate cancer. In this study, the effect of ASA‐treated prostate epithelial cells (RWPE‐1) on the proliferation and migration of prostate cancer cells was investigated. RWPE‐1 cells were exposed to different ASA concentrations, and non‐toxic concentrations were selected. Conditioned media (CM) from untreated and ASA‐treated RWPE‐1 cells were applied to PC‐3 prostate cancer cells. Cell viability was assessed using the MTT assay, while migration was evaluated using the wound‐healing assay, and colony formation was also assessed. ASA at 50 μM showed no cytotoxic effect on RWPE‐1 cells, while CM1 (ASA 50 μM) reduced PC‐3 cell viability to 60% . Moreover, CM1 (ASA 50 μM) and CM2 (ASA 25 μM) significantly inhibited PC‐3 cell migration. Comparing CM groups revealed that ASA exposure alters the secretome of prostate epithelial cells, thereby reducing cancer cell viability and motility. These findings suggest that ASA may serve as a promising chemopreventive and therapeutic agent for prostate cancer.  \n1 | Introduction  \nProstate cancer is a disease of old age, with the highest incidence in men around 70 years of age, except for hereditary cases [ 1] . Based on data from the World Health Organization (WHO) GLOBOCAN, it ranks as the second most common cancer among men globally. It is also the second leading cause of cancer‐related fatalities, after lung cancer. Men have an approximately one in eight chance of being diagnosed with prostate cancer during their lifetime, and the likelihood of dying from the disease is roughly 1 in 37 [2] . Prostate cancer is quite rare in men under the age of 40, and cases in this age group account for only a tiny percentage of all prostate cancer cases [3] .  \nThe human prostate is a gland located just below the bladder and is composed of glandular units known as acini, supported by a fibromuscular stroma. The epithelial compartment of the prostate consists primarily of two main cell types: basal cells and luminal secretory cells. Basal cells form a discontinuous layer along the basement membrane, whereas luminal cells line the inner surface of the acini and are responsible for secretory functions. Prostate epithelial stem and progenitor cells give rise to transit‐amplifying (TA) cells, which can differentiate into both basal and luminal cell lineages, maintaining epithelial homeostasis. In prostate cancer and its early stages, this organized epithelial architecture becomes disrupted, leading to increased cellular proliferation, loss of basal cell layer integrity, and expansion of luminal‐like tumor cells. Prostate tumors are  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s) . Cell Biochemistry and Function published by John Wiley & Sons Ltd.  \nCell Biochemistry and Func","cbCainzKRnXn4MNg","https://ap.wps.com/l/cbCainzKRnXn4MNg","pdf",2779776,"English","# Introduction\n## Prostate cancer background\n## Prostate epithelial structure and early disruption\n## Aspirin and anti-cancer rationale\n## Cellular and molecular signaling effects","[{\"question\":\"How were ASA-treated prostate epithelial conditioned media prepared for the study?\",\"answer\":\"RWPE-1 prostate epithelial cells were exposed to different ASA concentrations, with non-toxic doses selected. Conditioned media from untreated and ASA-treated RWPE-1 cells were collected and applied to PC-3 prostate cancer cells.\"},{\"question\":\"What methods were used to evaluate PC-3 cancer cell responses?\",\"answer\":\"Cell viability was assessed using the MTT assay, migration was evaluated with a wound-healing assay, and colony formation was also measured.\"},{\"question\":\"What were the main findings of ASA exposure on prostate cancer cells?\",\"answer\":\"ASA at 50 μM showed no cytotoxic effect on RWPE-1 cells, while conditioned media from ASA-treated epithelial cells reduced PC-3 viability to 60% and significantly inhibited PC-3 migration. The results indicate that ASA modifies the epithelial secretome to suppress cancer cell viability and motility.\"}]","Modulation of Prostate Cancer Cell Behavior Through Acetylsalicylic Acid-Treated Prostate Epithelial Cell-Derived Conditioned Medium - Research article | PDF",1790059466,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98d12a0c12d6dd746f76ef4a1789f8fc.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54c51a78c5fa56215169df84b963a162.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/590ede57104e75c8bb52a51a3ace5f65.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95892dc26b69604d070b864f9f37a0aa.webp",980,1287]